1,3,5-trimethyl-1H-pyrazole-4-carbonitrile, 95.0%, 1g

5-Hidroximetilfurfural, mínimo 97 %, para síntesis, 250 mg, envase de vidrio

(2R,3R)-3-(Ethoxycarbonyl)oxirane-2-carboxylic acid, 98%, 1g

2,4-Dinitro(trifluoromethoxy)benzene, 98.0%, 25g

2-Bromo-N,N,4-trimethylaniline, 95.0%, 1g

(S)-(+)-6,6'-Dibromo-1,1'-bi-2-naphthol>98.0%(HPLC)5g

(5,6-Dichloropyridin-3-yl)methanamine, 97%, 5g

5-(Bromomethyl)benzo[d]thiazole, 95.0%, 1g

Nifedipine, 98.0%, 5g

1-(2-Chloro-6-fluorophenyl)cyclopropanecarboxylic acid, 96%, 250mg

2-(3-Chloro-4-methylphenoxy)acetic acid, 95%, 1g

3,4-Bis(3-indolyl)maleimide, 95.0%, 250mg

2-(4-Chlorophenyl)-2-morpholinoacetonitrile hydrochloride, 95.0%, 5g